+ Watch BGMD
on My Watchlist
Big IHS pattern will run
Woo-hoo! CMS increased the reimbursement for the Galectin-3 test from $18 to $30! While that's certainly not a negative for BG Medicine, it doesn't address the fundamental problem with the test which is a lack of usefulness and a lack of demand. Quarterly utilization of the test has been flat and losses have been excessive given the amount of cash remaining. Expect a dip back towards the 50 cent mark on announcement of a new below market dilutive financing in the near future.
cecamadocv1 liked it.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions